Shilpa Medicare acquires Pilnova Pharma in United States

03 Nov 2023 Evaluate

Shilpa Medicare has acquired Pilnova Pharma, Inc in the United States on November 2, 2023, which will now be a wholly owned subsidiary of the company. The object of acquisition is to establish front end presence in the US Market with an objective to capture the full potential of its niche portfolios.

Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.


Shilpa Medicare Share Price

540.85 -13.05 (-2.36%)
03-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1508.40
Dr. Reddys Lab 6332.85
Cipla 1424.40
Zydus Lifesciences 992.00
Lupin 1663.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.